GoodRx (NASDAQ:GDRX) Price Target Cut to $5.50 by Analysts at Truist Financial
GoodRx (NASDAQ:GDRX – Free Report) had its price target cut by Truist Financial from $6.50 to $5.50 in a research note published on Thursday,Benzinga reports. They currently have a hold rating on the stock. GDRX has been the subject of several other research reports. Morgan Stanley reduced their price objective on shares of GoodRx from […]
GoodRx (NASDAQ:GDRX – Free Report) had its price target cut by Truist Financial from $6.50 to $5.50 in a research note published on Thursday,Benzinga reports. They currently have a hold rating on the stock. GDRX has been the subject of several other research reports. Morgan Stanley reduced their price objective on shares of GoodRx from […]
